ArticlebioRxiv : the preprint server for biology2024
Hierarchical Organization of Visual Feature Attention Control.
Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Attention can be deployed in anticipation of visual stimuli based on features such as their color or direction of motion. This anticipatory feature-based attention involves top-down neural control signals from the frontoparietal network that bias visual cortex to enhance the processing of attended information and suppress distraction. So, for example, anticipatory attention control can enable effective selection based on stimulus color while ignoring distracting information about stimulus motion. But as well, anticipatory attention can be focused more narrowly, for example, to select specific colors or motion directions that define task-relevant events and objects. One important question that remains open is whether anticipatory attention control first biases broad feature dimensions such as color versus motion before biasing the specific feature attributes (e.g., blue vs. green). To investigate this, we recorded EEG activity during a task where participants were cued to either attend to a color (blue or green) or a motion direction (up or down) on a trial-by-trial basis. Applying multivariate decoding approaches to the EEG alpha band (8-12 Hz) activity during the attention control period (cue-target interval), we observed significant decoding for both the attended dimensions (color vs. motion) and specific feature attributes (blue vs. green; up vs. down). Importantly, the temporal onset of the dimension-level biasing (color vs. motion) preceded that of the attribute-level biasing (e.g., blue vs. green). These findings demonstrate that the top-down control of feature-based attention proceeds in a hierarchical fashion, first biasing the broad feature dimension, and then narrowing to the specific feature attribute. Significance Statement: During voluntary feature-based attention, electrophysiological and neuroimaging studies have highlighted the role of anticipatory (top-down) biasing of the sensory cortex in enhancing the selection of attended stimulus attributes, but little is known about how this is achieved. In particular, it is not clear whether attending to an attribute such as a color (blue vs. green) or motion direction (up vs. down) first biases all neural structures coding that dimension (color/motion) before biasing the specific attribute, or if the top-down signals directly bias only the attended attribute. Using EEG and multivariate decoding, we report that top-down attention control follows a hierarchical organization: first, the broader attended feature dimension is biased, which is followed by the biasing of the specific feature attribute.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.